John Barthelow Classen

435 total citations
19 papers, 246 citations indexed

About

John Barthelow Classen is a scholar working on Genetics, Immunology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, John Barthelow Classen has authored 19 papers receiving a total of 246 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 9 papers in Immunology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in John Barthelow Classen's work include Diabetes and associated disorders (16 papers), Diabetes Management and Research (8 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). John Barthelow Classen is often cited by papers focused on Diabetes and associated disorders (16 papers), Diabetes Management and Research (8 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). John Barthelow Classen collaborates with scholars based in United States. John Barthelow Classen's co-authors include David C. Classen, E M Shevach and Ethan M. Shevach and has published in prestigious journals such as Transplantation, Pharmacoepidemiology and Drug Safety and Diabetes & Metabolic Syndrome Clinical Research & Reviews.

In The Last Decade

John Barthelow Classen

15 papers receiving 196 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Barthelow Classen United States 8 110 89 65 60 60 19 246
Terry-Nan Tannenbaum Canada 4 99 0.9× 22 0.2× 163 2.5× 185 3.1× 51 0.8× 5 308
Jessica J. Lee United States 5 96 0.9× 29 0.3× 98 1.5× 36 0.6× 11 0.2× 8 199
Jennifer Rebeles United States 5 50 0.5× 60 0.7× 149 2.3× 101 1.7× 9 0.1× 12 296
Sarah King United Kingdom 8 48 0.4× 12 0.1× 43 0.7× 21 0.3× 44 0.7× 17 314
Scott D. Neidich United States 3 36 0.3× 41 0.5× 100 1.5× 81 1.4× 5 0.1× 4 206
V. Matt Laurich United States 6 53 0.5× 12 0.1× 103 1.6× 95 1.6× 15 0.3× 10 289
Dimitri C. Cassimatis United States 5 14 0.1× 30 0.3× 81 1.2× 108 1.8× 13 0.2× 10 291
Sophie Valkenburg Australia 8 14 0.1× 73 0.8× 86 1.3× 127 2.1× 11 0.2× 10 328
G. Gutiérrez Spain 6 47 0.4× 39 0.4× 32 0.5× 22 0.4× 39 0.7× 6 176
Margaret Pollack United States 8 22 0.2× 38 0.4× 124 1.9× 30 0.5× 74 1.2× 10 338

Countries citing papers authored by John Barthelow Classen

Since Specialization
Citations

This map shows the geographic impact of John Barthelow Classen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Barthelow Classen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Barthelow Classen more than expected).

Fields of papers citing papers by John Barthelow Classen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Barthelow Classen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Barthelow Classen. The network helps show where John Barthelow Classen may publish in the future.

Co-authorship network of co-authors of John Barthelow Classen

This figure shows the co-authorship network connecting the top 25 collaborators of John Barthelow Classen. A scholar is included among the top collaborators of John Barthelow Classen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Barthelow Classen. John Barthelow Classen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Classen, John Barthelow, et al.. (2015). Metabolic surgery for the treatment of type 2 diabetes.
2.
3.
Classen, John Barthelow. (2012). Review of Evidence that Epidemics of Type 1 Diabetes and Type 2 Diabetes/ Metabolic Syndrome are Polar Opposite Responses to Iatrogenic Inflammation. Current Diabetes Reviews. 8(6). 413–418. 15 indexed citations
4.
5.
6.
7.
Classen, John Barthelow. (2008). Risk of Vaccine Induced Diabetes in Children with a Family History of Type 1 Diabetes. 2(1). 7–10. 3 indexed citations
8.
9.
10.
Classen, John Barthelow. (2006). Enhanced funding of pharmacoepidemiology through patenting the disclosure of adverse event information. Pharmacoepidemiology and Drug Safety. 15(6). 390–393.
11.
Classen, John Barthelow & David C. Classen. (2003). Clustering of Cases of Type 1 Diabetes Mellitus Occurring 2-4 Years After Vaccination is Consistent with Clustering After Infections and Progression to Type I Diabetes Mellitus in Autoantibody Positive Individuals. Journal of Pediatric Endocrinology and Metabolism. 16(4). 495–508. 16 indexed citations
12.
13.
Classen, John Barthelow & David C. Classen. (2001). Vaccines and the risk of insulin-dependent diabetes (IDDM): potential mechanism of action. Medical Hypotheses. 57(5). 532–538. 13 indexed citations
14.
Classen, John Barthelow & David C. Classen. (1999). Immunization in the First Month of Life may Explain Decline in Incidence of IDDM in the Netherlands. Autoimmunity. 31(1). 43–45. 14 indexed citations
15.
Classen, John Barthelow. (1998). Cyclosporine Induced Autoimmunity in Newborns Prevented by Early Immunization. Autoimmunity. 27(3). 135–139. 7 indexed citations
16.
Classen, David C. & John Barthelow Classen. (1997). The Timing of Pediatric Immunization and the Risk of Insulin-Dependent Diabetes Mellitus. Infectious Diseases in Clinical Practice. 6(7). 449–454. 52 indexed citations
17.
Classen, John Barthelow. (1996). The Timing of Immunization Affects the Development of Diabetes in Rodents. Autoimmunity. 24(3). 137–145. 45 indexed citations
18.
Classen, John Barthelow & Ethan M. Shevach. (1993). Post-Thymectomy Organ-Specific Autoimmunity: Enhancement by Cyclosporine A and Inhibition by IL-2. Autoimmunity. 15(1). 55–59. 6 indexed citations
19.
Classen, John Barthelow & E M Shevach. (1991). EVIDENCE THAT CYCLOSPORINE TREATMENT DURING PREGNANCY PREDISPOSES OFFSPRING TO DEVELOP AUTOANTIBODIES. Transplantation. 51(5). 1052–1057. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Terry-Nan Tannenbaum Breakdown of academic impact, for papers by Jessica J. Lee Breakdown of academic impact, for papers by Jennifer Rebeles Breakdown of academic impact, for papers by Sarah King Breakdown of academic impact, for papers by Scott D. Neidich Breakdown of academic impact, for papers by V. Matt Laurich Breakdown of academic impact, for papers by Dimitri C. Cassimatis Breakdown of academic impact, for papers by Sophie Valkenburg Breakdown of academic impact, for papers by G. Gutiérrez Breakdown of academic impact, for papers by Margaret Pollack
Rankless by CCL
2026